Clipping is a handy way to collect important slides you want to go back to later. Plasmacytoma is characterized by a local accumulation of monoclonal plasma cells without criteria for multiple myeloma mm. Thus, combining the abovementioned research results with the guidelines 9,28. Solitary plasmacytoma sp is a plasma cell disorder characterized by localized accumulation of neoplastic monoclonal plasma cells in bone, or in soft tissues with no skeletal component, without any evidence of systemic involvement as demonstrated by the lack of clonal plasma cells in the bone marrow and absence of features of endorgan damage. If the cancer is located in only one part of the body it is called a solitary plasmacytoma and if there are multiple sites it is called a multiple myeloma. Multiple myeloma is a type of blood cancer of the plasma cells which are found in the bone marrow. Plasmacytoma treatment chemotherapy, radiation, surgery. Radiation therapy for solitary plasmacytoma and multiple. Radiation therapy is the commonly used treatment for both the types of solitary plasmacytoma, as solitary plasmacytomas are localized and there is only one tumor present. The updated criteria for the diagnosis of myeloma represent a paradigm shift in the approach to myeloma and have considerable impact on the management of the disease. Multiple solitary plasmacytoma with multifocal bone. Pdf solitary bone plasmacytomas are part of a wide range of monoclonal neoplasms that share a common progenitor in the b lymphocyte lineage. It is potentially curable when it presents as a solitary plasmacytoma of bone or as an extramedullary plasmacytoma.
Solitary and extramedullary plasmacytoma department of clinical effectiveness v4 approved by the executive committee of the medical staff on 05292018 treat as plasmacytoma, see page 2 yes no 1 see physical activity, nutrition, and tobacco cessation algorithms. They then need additional treatment, such as chemotherapy. Additional information is now available on the role of serum free light chains and pet scanning. Solitary plasmacytoma of the bone is most commonly encountered in the axial skeleton skull, spine, pelvis, ribs, and sternum, accounting for 80% of cases. International myeloma working group imwg criteria for the diagnosis of multiple myeloma. Section a indication choose only one plasmactyoma pet for patients with presumed solitary plasmacytoma on conventional.
Adjuvant chemotherapy in the treatment of solitary bone plasmacytoma. Radiation therapy for the solitary plasmacytoma journalagent. Solitary plasmacytomas are uncommon plasma cell disorders, which may present as a single bone lesion pbone or extramedullary plasmacytoma pem. For spb and extramedullary plasmacytoma the distinction is the presence of only one lesion.
The prognosis and treatment of solitary plasmacytomas is very. Extramedullary plasmacytoma, prognostic factors, radiotherapy. Biopsy confirmation of a monoclonal plasma cell infiltration from a single site is required for diagnosis. Multiple myelomaplasmacytoma requisition to pet centre. It differs from multiple myeloma by the lack of hypercalcaemia, renal insufficiency, anaemia and pathological monoclonal plasmocytosis on a. Find out about solitary myeloma symptoms, diagnosis and treatment. Imwg criteria for the diagnosis of mm inl myeloma fn. However, 70 percent of people with solitary plasmacytoma eventually develop multiple myeloma. It is critical to determine if this is an isolated plasmacytoma or if the patients already has multiple myeloma see testing. Solitary bone plasmacytoma local radiotherapy is the treatment of choice for solitary bone plasmacytome sbp.
Multiple myeloma early detection, diagnosis, and staging. Diagnosis, treatment, and response assessment in solitary. Solitary mesenteric plasmacytoma revealed by an acute intestinal. Extramedullary plasmacytoma carries a better prognosis than a solitary plasmacytoma of the bone. The side effects of plasmacytoma treatment vary based on the treatment. Guidelines also recommend using the term sp with minimal bone marrow. Solitary plasmacytoma is an infrequent form of plasma cell dyscrasia that presents as a single mass of monoclonal plasma cells, located either extramedullary or intraosseous. We report four cases of solitary plasmacytoma of the bone and an extramedullary plasmacytoma of the paranasal sinuses and soft palate. It is divided into two categories based on location. The solitary plasmacytoma sp is characterized by a localized accumulation of neoplastic monoclonal plasma cells without a proof of a systemic plasma cell proliferative disorder. The current treatment regimen is local radiotherapy.
Plasmacytoma is a plasma cell dyscrasia in which a plasma cell tumour grows within soft tissue or within the axial skeleton. Multiple myeloma early detection, diagnosis, and staging 1. A plasmacytoma is a discrete, solitary mass of neoplastic monoclonal plasma. Plasmacytoma bone is the more common type than the plasmacytoma extramedullary type. Malignant bone tumours of the spine are extremely rare solitary plasmacytoma. Solitary plasmacytoma of bone spb, also called osseous plasmacytoma is a localized tumor in the bone comprised of a single clone of plasma cells in the absence of other features of mm ie, anemia, hypercalcemia, renal insufficiency, or multiple lytic bone lesions. It is important for the otolaryngologist to acquire knowledge of this disease. Progression of a solitary plasmacytoma to multiple myeloma. Diagnosis and management of solitary extramedullary. The prognosis and treatment of solitary plasmacytomas is very different to multiple myeloma. This may possibly be combined with a stem cell transplant. Original article the outcome and analysis of different. Multiple solitary plasmacytoma msp is a rare plasma cell dyscrasia, characterised by multiple lesions of neoplastic monoclonal plasma cells.
Solitary plasmacytoma sp is characterized by a mass of neoplastic monoclonal plasma cells in either bone sbp or soft tissue without evidence of systemic disease attributing to myeloma. Solitary plasmacytoma is an uncommon plasma cell neoplasm that accounts for 5% to 10% of all plasma cell neoplasms. The international myeloma working group lists three types. Between 1956 and 1978, nine patients with solitary plasmacytoma of bone spb and seven with extramedullary plasmacytoma emp were treated at the university of washington hospital and swedish tumor institute. The prognosis for plasmacytoma depends on whether the lesions are solitary or a sign of multiple myeloma. Longterm outcome of patients with solitary plasmacytoma treated. Less than 5% of patients with a plasma cell dyscrasia present with a single bone sbp or extramedullary plasmacytoma emp without evidence of systemic disease normocalcemia, absence of anemia, preservation of uninvolved immunoglobulins, or renal disease attributable to myeloma. If the diagnosis is plasmacytoma and there is no additional information to indicate if its a plasmacytoma of the bone or an extramedullary plasmacytoma, default to plasmacytoma of the bone and assign histology, 973. A solitary plasmacytoma of the bone is 40% more common than an extramedullary soft tissue plasmacytoma. In radiation therapy, there is focusing of radiation on the solitary plasmacytoma to destroy the abnormal cancerous cells.
Solitary plasmacytoma of bone and asymptomatic multiple. Plasmacytoma is a more benign condition than multiple myeloma, although it can develop into multiple myeloma. Plasmacytoma can be further divided into two distinct types, namely, solitary bone plasmacytoma and solitary extramedullary plasmacytoma. Extramedullary plasmacytoma is a plasma cell tumor that grows. Localized plasmacell neoplasms are rare, and include sp of the skeletal system. The definition of sp has been evolving as a result of improvement in imaging technology as well as the availability of more sensitive techniques that can detect small populations of clonal plasma cells in the bone marrow. Solitary plasmacytoma symptoms, diagnosis, treatments and. Treatment approaches and outcomes in plasmacytomas. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Solitary bone and extramedullary plasmacytoma hematology.
Multiple myeloma plasmacytoma requisition to pet centre to be completed by the referring physician. Radiation therapy for treating solitary plasmacytoma. It is an infrequent form of plasma cell neoplasm and represents 5% to 10% of all plasma cell neoplasms according to the literature 15. Solitary plasmacytoma and extramedullary plasmacytoma of. Currently, radiation therapy remains the primary choice of treatment for spb, as plasmacytoma is a radio. Now customize the name of a clipboard to store your clips. This is the least invasive treatment with the fewest side effects. It differs from multiple myeloma by the lack of hypercalcaemia, renal insufficiency, anaemia and pathological monoclonal plasmocytosis on a random bone. Plasma cell leukaemia is significantly more aggressive than myeloma and usually requires more intensive treatment. However, more than 50% of patients develop mm within 2 years after treatment. Plasmacytoma is a plasma cell dyscrasia in which a plasma cell tumour grows within soft tissue. If it is plasma cell neoplasm consistent with a plasmacytoma or multiple myeloma, then the case would be reportable. A type of cancer from plasma cells where the plasma cells multiply uncontrollably. Multiple myeloma may later develop in patients with solitary bone plasmacytoma 6584% at 10 years or extramedullary sites 1% at.
World health organization classification of tumours of haematopoietic and lymphoid tissues, swerdlow sh, campo e, harris nl, et al. Softtissue or nonosseous extramedullary plasmacytoma emp solitary bone plasmacytoma sbp multifocal form of multiple myeloma multiple myeloma plasmablastic sarcoma t. Spb generally occurs in the pelvis, femur, humerus, and rib. Although radiotherapy has become the standard treatment for sp, there is no.
The common presentation of sbp is in the axial skeleton, whereas the extramedullary plasmacytoma. Solitary bone plasmacytoma is a lesion of the bone whereas solitary extramedullary plasmacytoma is a lesion of soft tissue. The involved free light chain must be greater than or equal to 100 mgl. A solitary plasmacytoma is a single cancer site that may involve the bone osseous or other tissues extraosseous or extramedullary. Pdf solitary extramedullary plasmacytoma of the bladder. Solitary plasmacytoma sp is the clinical condition characterized by the localized proliferation of clonal plasma cells.
A populationbased registry was consulted for the diagnosis of solitary plasmacytoma between. Solitary extramedullary plasmacytoma of the true vocal. Diagnosis and management of solitary plasmacytoma of bone. Solitary plasmacytoma is usually considered to be the diagnosis in cases where only one plasma cell tumour is found. Solitary or extramedullary plasmacytoma memorial sloan. Plasmocytome solitaire du mesentere revele par une occlusion intestinale. Radiotherapy is the common modality of treatment with, or without, adjuvant chemotherapy.
Plasmacytoma refers to a tumour consisting of abnormal plasma cells that grows within the. Current guidelines stipulate that head and neck emp be treated with. Learn about myeloma plasmacytoma solitary myeloma and how it differs from multiple myeloma. In some patients, a bone marrow aspiration can detect a low monoclonal plasma cell infiltration which indicates a high risk of early progression to an overt myeloma disease. Solitary bone plasmacytoma and extramedullary plasmacytoma. Guidelines on the diagnosis and management of solitary.
A plasmacytoma is a discrete, solitary mass of neoplastic monoclonal plasma cells in either bone or soft tissue extramedullary. Solitary plasmacytoma of the bone can sometimes be cured with radiation therapy or surgery to destroy or remove the tumor. Types of treatment for plasmacytoma include radiotherapy, surgery and chemotherapy. Bird, guidelines on the diagnosis and management of solitary plasmacytoma of bone, extramedullary plasmacytoma and multiple solitary plasmacytomas. Radiotherapy is the first choice of treatment in most cases. Primary plasmacytoma was characterized as solitary bone plasmacytoma when a single bone plasmacytoma was present 2, 3, solitary extramedullary plasmacytoma when a solitary softtissue plasmacytoma was present, or multiple solitary plasmacytoma when there was more than one localized bone or extramedullary tumor of clonal plasma cells 1. Solitary plasmacytoma is treated by radiotherapy or surgery.
731 1041 769 26 1019 1273 437 660 314 203 706 689 1398 801 827 1268 1432 966 1346 857 495 82 1038 274 1137 232 1428 1323 175 788